State-of-the-Art: Understanding the Genetics of CVID: Bench to Bedside
Monday, March 7, 2016: 3:30 PM-4:30 PM
Convention Center, Level Two, Room 501C
1.00 CME/CE

Learning Objectives:
  1. Discuss the current field of next generation sequencing and utility of this technology in the study of complex medical disorders including CVID
  2. Describe the current genetics of CVID including newly discovered genes and how understanding the genetics affects prognosis may alter medical decisions making especially for CVID associated complications such as malignancy and GLILD
  3. Discuss how understanding the genetics of CVID affects family planning, testing of minor children and genetic counseling
Discussion Leader
Michael Keller, MD
Discussion Leader
John Sleasman, MD
See more of: Session